A new bromelain-based enzyme for the release of Dupuytren’s contracture: Dupuytren’s enzymatic bromelain-based release

OBJECTIVES: Injectable Bromelain Solution (IBS) is a modified investigational derivate of the medical grade bromelain-debriding pharmaceutical agent (NexoBrid) studied and approved for a rapid (four-hour single application), eschar-specific, deep burn debridement. We conducted an ex vivo study to de...

Descripción completa

Detalles Bibliográficos
Autores principales: Rubin, G., Rinott, M., Wolovelsky, A., Rosenberg, L., Shoham, Y., Rozen, N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2016
Materias:
Upper Limb
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4921045/
https://www.ncbi.nlm.nih.gov/pubmed/27174554
http://dx.doi.org/10.1302/2046-3758.55.BJR-2016-0072

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4921045/
https://www.ncbi.nlm.nih.gov/pubmed/27174554
http://dx.doi.org/10.1302/2046-3758.55.BJR-2016-0072

Ejemplares similares